{
  "schema_version": "0.1.0",
  "case_id": "HR-NI007",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "NI007",
    "display_name": "John Henry Holliday",
    "aliases": [
      "Doc Holliday"
    ],
    "sex": "male",
    "era": "19th Century",
    "nationality": "American",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1851-08-14",
          "display": "August 14, 1851",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1851",
              "display": "1851",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0004"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the preferred source."
          },
          {
            "date": {
              "iso": "1852-08-14",
              "display": "August 14, 1852",
              "precision": "day",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0002"
            ],
            "resolution_status": "conflicting",
            "note": "The Encyclopedia of the Great Plains gives 1852; the New Georgia Encyclopedia gives 1851, which is preferred."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1887-11-08",
          "display": "November 8, 1887",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1887",
              "display": "1887",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0004"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-NI007-SYN",
      "ssn": "000-07-8153",
      "date_of_birth": "2004-08-14",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Martin Beaumont, MD",
      "fictional_consultant": {
        "name": "Leticia Navarro, MD",
        "specialty": "Infectious Diseases"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1851-08-14",
        "display": "August 14, 1851",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born in Griffin, Georgia.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1866",
        "display": "1866",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "His mother died of tuberculosis.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1872",
        "display": "1872",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Graduated from the Pennsylvania College of Dental Surgery and began practicing dentistry in Atlanta.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1873",
        "display": "1873",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Diagnosed with tuberculosis and advised to move to a drier climate.",
      "claim_ids": [
        "CLM-0004",
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1873-09",
        "display": "September 1873",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Arrived in Dallas, Texas.",
      "claim_ids": [
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1887-11-08",
        "display": "November 8, 1887",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Died of tuberculosis in Glenwood Springs, Colorado.",
      "claim_ids": [
        "CLM-0007"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "John Henry Holliday was born on August 14, 1851, in Griffin, Georgia.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "In 1866 Holliday's mother died of tuberculosis.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Family history of pulmonary tuberculosis.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "He enrolled at the Pennsylvania College of Dental Surgery in 1870 and graduated in 1872, then practiced dentistry in Atlanta before opening his own practice in Griffin.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Supports his occupation as a newly qualified dentist in the modern episode.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "Shortly after beginning his career as a dentist in Atlanta he developed a bad cough; doctors diagnosed tuberculosis and advised a move to a more arid climate. He developed chronic pulmonary tuberculosis.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchor for the modern pulmonary tuberculosis.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "He was diagnosed with tuberculosis in 1873 and moved west for a healthier, drier climate, arriving in Dallas, Texas, in September 1873.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Dates the diagnosis; the episode's true frame ends before the move.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "He made his living at the card tables, aggravating his tuberculosis with heavy drinking and late nights.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchor for the modern alcohol use disorder; the source does not date the heavy drinking.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0007",
      "statement": "He died of tuberculosis in its final stages on November 8, 1887, in Glenwood Springs, Colorado, at the age of 36.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Recorded as a fact; the modern episode ends with cure.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "John Henry \"Doc\" Holliday (1851-1887)",
      "publisher": "New Georgia Encyclopedia (Georgia Humanities)",
      "url": "https://www.georgiaencyclopedia.org/articles/history-archaeology/john-henry-doc-holliday-1851-1887/",
      "source_type": "scholarly",
      "published": "2009-08-28",
      "accessed": "2026-11-02",
      "rights_note": "Encyclopedia article by John Dalton Macdonald, University of Georgia, last edited January 13, 2022; facts used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Holliday, Doc (1852-1887)",
      "publisher": "Encyclopedia of the Great Plains (University of Nebraska-Lincoln)",
      "url": "https://plainshumanities.unl.edu/encyclopedia/doc/egp.ii.035.html",
      "source_type": "scholarly",
      "published": null,
      "accessed": "2026-11-02",
      "rights_note": "Encyclopedia entry by Derrick S. Ward; facts used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "Doc Holliday dies of tuberculosis",
      "publisher": "HISTORY.com (A&E Television Networks)",
      "url": "https://www.history.com/this-day-in-history/november-8/doc-holliday-dies-of-tuberculosis",
      "source_type": "other",
      "published": "2009-11-16",
      "accessed": "2026-11-02",
      "rights_note": "This Day in History article by the HISTORY.com editors, last updated May 27, 2025; facts used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-01",
      "accessed": "2026-11-02",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-02-10",
    "index_age": 21,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Diagnosis and six-month treatment of drug-susceptible cavitary pulmonary tuberculosis in a 21-year-old dentist under the ATS/CDC/IDSA guideline (three sputum smears, nucleic acid amplification, culture and susceptibility, HIV and hepatitis testing, baseline liver tests and vision checks, isoniazid, rifampin, pyrazinamide, and ethambutol for eight weeks then isoniazid and rifampin for eighteen weeks by video-observed therapy, stopping ethambutol on susceptibility results, monthly liver and symptom monitoring, release from isolation, two-month culture conversion, contact investigation, and public-health reporting), together with care for an alcohol use disorder that raises the risk of isoniazid liver injury (AUDIT, brief intervention, counseling, and a structured safety assessment with the 988 Suicide & Crisis Lifeline), and an honest account of a liver-monitoring gap.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-02-10",
        "purpose": "Diagnosis of cavitary pulmonary tuberculosis: sputum, chest X-ray, baseline tests, public-health report, home isolation, and alcohol assessment with a safety assessment"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-02-24",
        "purpose": "Two-week follow-up on treatment with infectious diseases consultation"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-03-17",
        "purpose": "Five-week review: susceptibility results, release from isolation, and liver monitoring"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-04-14",
        "purpose": "End of the intensive phase: two-month sputum and the start of the continuation phase"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-05-19",
        "purpose": "Same-day sick visit for nausea and vomiting during tuberculosis treatment"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-08-18",
        "purpose": "End-of-treatment review after six months"
      },
      {
        "encounter_id": "ENC-007",
        "date": "2026-09-22",
        "purpose": "Adult preventive visit"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Pulmonary tuberculosis, right upper lobe cavitary, sputum smear-positive, confirmed by nucleic acid amplification without rifampin resistance",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "A15.0",
            "display": "Tuberculosis of lung",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern coding of his documented pulmonary tuberculosis at the time of diagnosis; the bacteriology is synthetic.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-002",
        "display": "Alcohol use disorder, mild, with binge drinking",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "F10.10",
            "display": "Alcohol abuse, uncomplicated",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic modern coding anchored to the documented heavy drinking; the severity and the criteria met are synthetic.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-003",
        "display": "Acute viral gastroenteritis during tuberculosis treatment, with a mild aminotransferase rise below the threshold for drug-induced liver injury; resolved",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "A08.4",
            "display": "Viral intestinal infection, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic intercurrent illness chosen to teach the assessment of nausea on isoniazid and rifampin; it does not echo a documented illness.",
          "author": "The Human Record generator",
          "created": "2026-11-03T16:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-05-19"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Isoniazid 300 mg tablet, one tablet daily",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "197832",
            "display": "isoniazid 300 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "dose": {
          "value": 300,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "300 mg once daily by video-observed therapy with the health department, seven days a week, for six months"
        },
        "start_date": "2026-02-12",
        "end_date": "2026-08-13",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic standard regimen (about 5 mg/kg) for drug-susceptible pulmonary tuberculosis.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Rifampin 300 mg capsules, two capsules (600 mg) daily",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198202",
            "display": "rifampin 300 MG Oral Capsule",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "dose": {
          "value": 600,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "600 mg once daily on an empty stomach by video-observed therapy with the health department, seven days a week, for six months"
        },
        "start_date": "2026-02-12",
        "end_date": "2026-08-13",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic standard regimen (about 10 mg/kg).",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Pyrazinamide 500 mg tablets, three tablets (1500 mg) daily",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198181",
            "display": "pyrazinamide 500 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "dose": {
          "value": 1500,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "1500 mg once daily by video-observed therapy with the health department, seven days a week, for the eight-week intensive phase"
        },
        "start_date": "2026-02-12",
        "end_date": "2026-04-08",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic weight-band dose for 56 to 75 kg in the intensive phase.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Ethambutol 400 mg tablets, three tablets (1200 mg) daily",
        "status": "stopped",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "995607",
            "display": "ethambutol hydrochloride 400 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "dose": {
          "value": 1200,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "1200 mg once daily by video-observed therapy with the health department, seven days a week, until susceptibility results return"
        },
        "start_date": "2026-02-12",
        "end_date": "2026-03-10",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic weight-band dose; stopped when the isolate proved susceptible to isoniazid and rifampin.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Vitamin B6 (pyridoxine) 50 mg tablet, one tablet daily",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "639566",
            "display": "vitamin B6 50 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "dose": {
          "value": 50,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "50 mg once daily with isoniazid"
        },
        "start_date": "2026-02-12",
        "end_date": "2026-08-13",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic neuropathy prevention with isoniazid in a person who drinks heavily.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 12.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 16.6
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic baseline result before starting tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V1",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 9.4,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic baseline result before starting tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 412,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "H",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic baseline result before starting tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 34,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic baseline result before starting tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V1",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 38,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic baseline result before starting tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V1",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 0.6,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic baseline result before starting tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALP-V1",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 92,
        "unit": "U/L",
        "reference_range": {
          "low": 40,
          "high": 129
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic baseline result before starting tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-GGT-V1",
        "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "GGT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 78,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 61
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2324-2",
            "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic baseline result before starting tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V1",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 3.4,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic baseline result before starting tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 0.86,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic baseline result before starting tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 124,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic baseline result before starting tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 90,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic baseline result before starting tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V1",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "HbA1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-10",
        "value": 5.2,
        "unit": "%",
        "reference_range": {
          "high": 5.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic baseline result before starting tuberculosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-VAOD-V1",
        "display": "Visual acuity uncorrected Right eye by ETDRS eye chart",
        "label": "Visual acuity, right eye (ETDRS letters)",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-02-10",
        "value": 85,
        "unit": "{letters}",
        "reference_range": {
          "low": 80
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "79878-5",
            "display": "Visual acuity uncorrected Right eye by ETDRS eye chart",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic baseline uncorrected acuity before ethambutol (85 letters, about 20/20).",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-VAOS-V1",
        "display": "Visual acuity uncorrected Left eye by ETDRS eye chart",
        "label": "Visual acuity, left eye (ETDRS letters)",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-02-10",
        "value": 85,
        "unit": "{letters}",
        "reference_range": {
          "low": 80
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "79879-3",
            "display": "Visual acuity uncorrected Left eye by ETDRS eye chart",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic baseline uncorrected acuity before ethambutol.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDIT-V1",
        "display": "Total score [AUDIT]",
        "label": "AUDIT",
        "status": "final",
        "effective_date": "2026-02-10",
        "value": 15,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75624-7",
            "display": "Total score [AUDIT]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic full AUDIT: drinking four or more evenings a week, often six or more drinks, with two harm items; anchored to the documented heavy drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V1",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-02-10",
        "value": 9,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic AUDIT-C, the first three AUDIT items.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V1",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-02-10",
        "value": 6,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen; mild symptoms from the illness and its news; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V2",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-24",
        "value": 41,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic two-week liver check; drinking raises the risk of drug-induced liver injury.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V2",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-24",
        "value": 39,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic two-week liver check; drinking raises the risk of drug-induced liver injury.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V2",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-24",
        "value": 0.7,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic two-week liver check; drinking raises the risk of drug-induced liver injury.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-VAOD-V2",
        "display": "Visual acuity uncorrected Right eye by ETDRS eye chart",
        "label": "Visual acuity, right eye (ETDRS letters)",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-02-24",
        "value": 85,
        "unit": "{letters}",
        "reference_range": {
          "low": 80
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "79878-5",
            "display": "Visual acuity uncorrected Right eye by ETDRS eye chart",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic acuity check on ethambutol.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-VAOS-V2",
        "display": "Visual acuity uncorrected Left eye by ETDRS eye chart",
        "label": "Visual acuity, left eye (ETDRS letters)",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-02-24",
        "value": 84,
        "unit": "{letters}",
        "reference_range": {
          "low": 80
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "79879-3",
            "display": "Visual acuity uncorrected Left eye by ETDRS eye chart",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic acuity check on ethambutol; unchanged within test variability.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V2",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-02-24",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic AUDIT-C for the past two weeks; cutting down.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V3",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-17",
        "value": 52,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic monthly liver check on isoniazid, rifampin, and pyrazinamide.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V3",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-17",
        "value": 47,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic monthly liver check on isoniazid, rifampin, and pyrazinamide.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V3",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-17",
        "value": 0.8,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic monthly liver check on isoniazid, rifampin, and pyrazinamide.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V3",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-03-17",
        "value": 2,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic AUDIT-C for the past month.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V4",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-14",
        "value": 38,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic two-month liver check.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V4",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-14",
        "value": 35,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic two-month liver check.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V4",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-14",
        "value": 0.7,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic two-month liver check.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V4",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-04-14",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic AUDIT-C for the past month.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V5",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-18",
        "value": 30,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic end-of-treatment result.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V5",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-18",
        "value": 28,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic end-of-treatment result.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V5",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-18",
        "value": 0.6,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic end-of-treatment result.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V5",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-18",
        "value": 14.4,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 16.6
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic end-of-treatment result.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V5",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-08-18",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic AUDIT-C for the past month.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V5",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-08-18",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic end-of-treatment mood screen; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-SICK",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-19",
        "value": 64,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic same-day liver tests for nausea and vomiting on isoniazid and rifampin.",
          "author": "The Human Record generator",
          "created": "2026-11-03T16:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-SICK",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-19",
        "value": 58,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic same-day liver tests for nausea and vomiting on isoniazid and rifampin.",
          "author": "The Human Record generator",
          "created": "2026-11-03T16:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-SICK",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-19",
        "value": 0.9,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic same-day liver tests for nausea and vomiting on isoniazid and rifampin.",
          "author": "The Human Record generator",
          "created": "2026-11-03T16:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALP-SICK",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-19",
        "value": 98,
        "unit": "U/L",
        "reference_range": {
          "low": 40,
          "high": 129
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic same-day liver tests for nausea and vomiting on isoniazid and rifampin.",
          "author": "The Human Record generator",
          "created": "2026-11-03T16:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-SICK",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-05-19",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic AUDIT-C for the past month, raised by one evening of heavy drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-03T16:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-PREV",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-09-22",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-03T16:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-PREV",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-09-22",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic yearly alcohol screen.",
          "author": "The Human Record generator",
          "created": "2026-11-03T16:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Chest X-ray, two views: right upper lobe consolidation with a 3 cm thick-walled cavity; no effusion or hilar enlargement",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "399208008",
            "display": "Plain X-ray of chest",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "period": {
          "start": "2026-02-10",
          "end": "2026-02-10"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic diagnostic chest X-ray.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "Chest X-ray, two views, at the end of treatment: cavity closed, with residual right upper lobe scarring; kept as the baseline for any future comparison",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "399208008",
            "display": "Plain X-ray of chest",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "period": {
          "start": "2026-08-18",
          "end": "2026-08-18"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic end-of-treatment chest X-ray.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Tetanus, diphtheria, and pertussis (Tdap) booster",
        "status": "completed",
        "date": "2022-08-30",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult immunization history in the modern frame; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Influenza vaccine, 2026-2027 season",
        "status": "completed",
        "date": "2026-09-22",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic yearly influenza vaccination, recommended for health-care personnel.",
          "author": "The Human Record generator",
          "created": "2026-11-03T16:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Hepatitis B vaccine (HepB-CpG), dose 1 of 2",
        "status": "completed",
        "date": "2026-09-22",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first dose for a health-care worker who was not immune at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-03T16:00:00-05:00"
        }
      }
    ],
    "family_history": [
      {
        "id": "FH-001",
        "relationship": {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode",
          "code": "MTH",
          "display": "mother"
        },
        "condition": "Pulmonary tuberculosis; died of it in 1866",
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Developed a bad cough shortly after beginning to practice dentistry",
        "historical_date": {
          "iso": "1872",
          "display": "1872",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "Diagnosis of cavitary pulmonary tuberculosis: sputum, chest X-ray, baseline tests, public-health report, home isolation, and alcohol assessment with a safety assessment",
        "status": "finished",
        "date": "2026-02-10",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Two-week follow-up on treatment with infectious diseases consultation",
        "status": "finished",
        "date": "2026-02-24",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Two-week follow-up on tuberculosis treatment, seen the same day by infectious diseases",
          "hpi": {
            "narrative": "Mr. Holliday is a 21-year-old dentist with cavitary pulmonary tuberculosis who returns two weeks after diagnosis and is seen by infectious diseases today. He started isoniazid, rifampin, pyrazinamide, ethambutol, and pyridoxine two days after the first visit, once the nucleic acid amplification test confirmed tuberculosis, and has taken all thirteen doses on daily video calls with the health department nurse. His cough is less frequent, the blood streaks in his sputum have stopped, and the night sweats are lighter. He has mild nausea in the hour after the morning doses, eased by taking them at bedtime with a small snack. His urine and tears are orange, as he was warned. He has no yellowing, dark urine, abdominal pain, rash, numbness, or change in vision or color. He is isolating at home and not working; his roommate is being tested by the health department. He has cut down to a drink or two on three evenings in the two weeks and has not played cards. He feels low about being away from his practice but has no thoughts of suicide.",
            "elements": [
              {
                "label": "Treatment",
                "value": "Thirteen of thirteen doses observed by video"
              },
              {
                "label": "Symptoms",
                "value": "Less cough, no further blood in the sputum, lighter night sweats"
              },
              {
                "label": "Side effects",
                "value": "Mild nausea after morning doses; orange urine and tears"
              },
              {
                "label": "Alcohol",
                "value": "Cut down; AUDIT-C 4 for the past two weeks"
              },
              {
                "label": "Isolation",
                "value": "At home; off work"
              }
            ]
          },
          "ros": [
            {
              "system": "Respiratory",
              "status": "positive",
              "finding": "Cough less frequent; no blood in the sputum for a week; no breathlessness"
            },
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Lighter night sweats; no fever for five days; appetite returning"
            },
            {
              "system": "Gastrointestinal",
              "status": "positive",
              "finding": "Mild nausea after doses; no vomiting, abdominal pain, or jaundice"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No blurred vision or change in color vision"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No numbness or tingling"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Low about isolation and time off work; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Thin, less tired; weight 59.0 kg, up 1.0 kg; temperature 37.3 °C, heart rate 92; seen in a negative-pressure room with a respirator"
            },
            {
              "system": "Eyes",
              "finding": "No icterus. Visual acuity 85 letters on the right and 84 on the left; Ishihara plates read correctly with each eye"
            },
            {
              "system": "Respiratory",
              "finding": "Coarse crackles and bronchial breathing over the right upper zone, less than two weeks ago"
            },
            {
              "system": "Abdomen",
              "finding": "Soft and non-tender; liver not enlarged"
            },
            {
              "system": "Neurological",
              "finding": "Normal sensation and reflexes in the feet"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Cavitary pulmonary tuberculosis, intensive phase",
              "assessment": "Early clinical response and full adherence. Baseline sputum cultures are growing Mycobacterium tuberculosis complex; susceptibility results are pending. ALT 41, AST 39, and bilirubin 0.7 at two weeks, all normal. Vision normal on ethambutol. HIV negative; hepatitis B and C serology negative, with no hepatitis B immunity. Infectious diseases agrees with the standard regimen and plan",
              "plan": [
                "Continue the four drugs and pyridoxine daily by video-observed therapy, taken at bedtime with a snack",
                "Three sputum samples on consecutive mornings in one week for the release decision",
                "Stop ethambutol once the isolate is shown to be susceptible to isoniazid and rifampin",
                "Liver tests monthly throughout treatment; stop the doses and call the same day for hepatitis symptoms"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder, mild",
              "assessment": "Drinking already cut down. Safety reviewed: no thoughts of suicide",
              "plan": [
                "Goal agreed: no alcohol until treatment ends",
                "First session with a substance-use counselor by video next week",
                "Medication offered (acamprosate, which does not affect the liver); he prefers counseling first"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Symptom review: cough, sputum, hemoptysis, fever, night sweats",
              "cadence": "At least monthly during treatment",
              "status": "completed_today",
              "detail": "Cough and night sweats improving; no hemoptysis for a week",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight",
              "cadence": "At least monthly during treatment",
              "status": "completed_today",
              "detail": "59.0 kg, up 1.0 kg",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Hepatitis symptom review (nausea, vomiting, abdominal pain, jaundice, dark urine)",
              "cadence": "Every visit and every observed dose",
              "status": "completed_today",
              "detail": "Mild nausea only, eased by bedtime dosing; no jaundice, dark urine, or pain",
              "guideline_ids": [
                "GL-ATS-TB-2016",
                "GL-ATS-HEPATOTOX-2006"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (ALT, AST, bilirubin)",
              "cadence": "Baseline, at two weeks, then monthly because of alcohol use",
              "status": "completed_today",
              "detail": "ALT 41, AST 39 U/L, bilirubin 0.7 mg/dL, all normal",
              "observation_ids": [
                "OBS-ALT-V2",
                "OBS-AST-V2",
                "OBS-TBIL-V2"
              ],
              "guideline_ids": [
                "GL-ATS-TB-2016",
                "GL-ATS-HEPATOTOX-2006"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Visual acuity and color vision",
              "cadence": "Baseline and monthly while on ethambutol",
              "status": "completed_today",
              "detail": "85 letters on the right and 84 on the left; color vision normal",
              "observation_ids": [
                "OBS-VAOD-V2",
                "OBS-VAOS-V2"
              ],
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Nucleic acid amplification test with rifampin resistance",
              "cadence": "At diagnosis",
              "status": "up_to_date",
              "detail": "Mycobacterium tuberculosis detected, rifampin resistance not detected, on the first sample",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Sputum AFB smear and culture",
              "cadence": "Monthly until two consecutive cultures are negative",
              "status": "completed_today",
              "detail": "Baseline smears 2+, 2+, and 3+; cultures growing Mycobacterium tuberculosis complex; release smears ordered for next week",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Drug susceptibility testing of the first isolate",
              "cadence": "Once, on the first positive culture",
              "status": "ordered",
              "detail": "Pending on the baseline isolate",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "HIV test",
              "cadence": "At diagnosis",
              "status": "up_to_date",
              "detail": "HIV-1/2 antigen and antibody test negative at diagnosis",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis B and C serology",
              "cadence": "At diagnosis",
              "status": "up_to_date",
              "detail": "Hepatitis B surface antigen, surface antibody, and core antibody negative; hepatitis C antibody negative; not immune to hepatitis B",
              "guideline_ids": [
                "GL-ATS-TB-2016",
                "GL-ATS-HEPATOTOX-2006"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Diabetes screen",
              "cadence": "At diagnosis",
              "status": "up_to_date",
              "detail": "HbA1c 5.2 percent at diagnosis",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Chest X-ray",
              "cadence": "At diagnosis; at two months only if the first cultures were negative; at the end of treatment as a new baseline",
              "status": "up_to_date",
              "detail": "Right upper lobe cavity at diagnosis",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Doses observed and missed (video-observed therapy)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Thirteen of thirteen doses observed",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Peripheral neuropathy check, with pyridoxine",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No neuropathy; pyridoxine 50 mg daily",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Rifampin drug-interaction review",
              "cadence": "With every new medicine",
              "status": "completed_today",
              "detail": "No other medicines; told that rifampin interacts with many drugs and stains contact lenses",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Home isolation and the criteria for release",
              "cadence": "Until three negative smears, clinical improvement, and two weeks of treatment",
              "status": "completed_today",
              "detail": "Isolating at home with no visitors; off work",
              "guideline_ids": [
                "GL-CDC-CONTACT-2005",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "referral",
              "measure": "Contact investigation (household, coworkers, patients)",
              "cadence": "Led by the health department, from diagnosis",
              "status": "referred",
              "detail": "Health department testing his roommate and assessing coworkers and the patients he treated in the last three months; their results are not part of his record",
              "guideline_ids": [
                "GL-CDC-CONTACT-2005",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "referral",
              "measure": "Report to the local health department",
              "cadence": "At diagnosis",
              "status": "up_to_date",
              "detail": "Reported the day of diagnosis",
              "guideline_ids": [
                "GL-CDC-CONTACT-2005",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "survey",
              "measure": "Alcohol use (AUDIT-C for the past month)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "AUDIT-C 4 for the past two weeks, down from 9",
              "observation_ids": [
                "OBS-AUDITC-V2"
              ],
              "guideline_ids": [
                "GL-USPSTF-ALC-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Brief counseling about alcohol and liver risk",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Agreed goal of no alcohol during treatment",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "referral",
              "measure": "Counseling with a substance-use counselor",
              "cadence": "Every one to two weeks during treatment",
              "status": "ordered",
              "detail": "First video session next week",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medication for alcohol use disorder",
              "cadence": "Offered for alcohol use disorder",
              "status": "not_indicated",
              "detail": "Acamprosate offered; he prefers counseling first for a mild disorder",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review and safety plan, with the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No thoughts of suicide; the 988 Suicide & Crisis Lifeline is in his phone",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "referral",
              "measure": "Infectious diseases consultation",
              "cadence": "Once at diagnosis, then as advised",
              "status": "completed_today",
              "detail": "Seen today",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            }
          ],
          "follow_up": "Release smears next week. Five-week review with susceptibility results. Call the same day for hepatitis symptoms",
          "guideline_ids": [
            "GL-ATS-TB-2016",
            "GL-ATS-HEPATOTOX-2006",
            "GL-CDC-CONTACT-2005",
            "GL-USPSTF-ALC-2018",
            "GL-SUD-2021",
            "GL-SUICIDE-2024"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Five-week review: susceptibility results, release from isolation, and liver monitoring",
        "status": "finished",
        "date": "2026-03-17",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Five-week review: susceptibility results, release from isolation, and liver monitoring",
          "hpi": {
            "narrative": "Mr. Holliday returns five weeks into treatment. The isolate is susceptible to isoniazid, rifampin, pyrazinamide, and ethambutol, and ethambutol was stopped a week ago when the result arrived. The three sputum smears collected in the third week were negative, and with his clinical improvement and more than two weeks of treatment he was released from home isolation two weeks ago and returned to work the following week. His cough is now occasional and dry, and the night sweats have stopped. He has taken every dose by video. He has no nausea now, no yellowing, dark urine, abdominal pain, numbness, or vision change. He has not had a drink in three weeks and has met his counselor twice. His roommate's first blood test was negative and will be repeated by the health department.",
            "elements": [
              {
                "label": "Susceptibility",
                "value": "Susceptible to all four first-line drugs; ethambutol stopped a week ago"
              },
              {
                "label": "Infection control",
                "value": "Three negative smears; released from isolation and back at work"
              },
              {
                "label": "Symptoms",
                "value": "Occasional dry cough; no night sweats"
              },
              {
                "label": "Alcohol",
                "value": "None for three weeks; two counseling sessions"
              }
            ]
          },
          "ros": [
            {
              "system": "Respiratory",
              "status": "positive",
              "finding": "Occasional dry cough; no sputum or blood"
            },
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever or night sweats; appetite good"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No nausea, abdominal pain, or jaundice"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood better since returning to work; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 61.0 kg; temperature 36.8 °C"
            },
            {
              "system": "Eyes",
              "finding": "No icterus"
            },
            {
              "system": "Respiratory",
              "finding": "A few crackles at the right apex; no bronchial breathing"
            },
            {
              "system": "Abdomen",
              "finding": "Soft; liver not enlarged or tender"
            },
            {
              "system": "Neurological",
              "finding": "Normal sensation in the feet"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Drug-susceptible pulmonary tuberculosis, intensive phase",
              "assessment": "Good response, with sputum smear conversion. AST 47 U/L is slightly above the upper limit, with ALT 52 and bilirubin 0.8 normal and no symptoms; this is well below the threshold for drug-induced liver injury",
              "plan": [
                "Continue isoniazid, rifampin, pyrazinamide, and pyridoxine daily by video; ethambutol stays stopped",
                "Liver tests again at the two-month visit",
                "Sputum culture again at the two-month visit, which decides whether the continuation phase lasts four or seven months"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder, mild",
              "assessment": "No alcohol for three weeks; AUDIT-C 2 for the past month. Safety reviewed: no thoughts of suicide",
              "plan": [
                "Continue counseling every two weeks",
                "Keep to no alcohol while the liver is under strain from three drugs"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Symptom review: cough, sputum, hemoptysis, fever, night sweats",
              "cadence": "At least monthly during treatment",
              "status": "completed_today",
              "detail": "Occasional dry cough only",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight",
              "cadence": "At least monthly during treatment",
              "status": "completed_today",
              "detail": "61.0 kg, up 3.0 kg since diagnosis",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Hepatitis symptom review (nausea, vomiting, abdominal pain, jaundice, dark urine)",
              "cadence": "Every visit and every observed dose",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-ATS-TB-2016",
                "GL-ATS-HEPATOTOX-2006"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (ALT, AST, bilirubin)",
              "cadence": "Baseline, at two weeks, then monthly because of alcohol use",
              "status": "completed_today",
              "detail": "ALT 52 U/L normal, AST 47 U/L slightly high, bilirubin 0.8 mg/dL normal; no symptoms",
              "observation_ids": [
                "OBS-ALT-V3",
                "OBS-AST-V3",
                "OBS-TBIL-V3"
              ],
              "guideline_ids": [
                "GL-ATS-TB-2016",
                "GL-ATS-HEPATOTOX-2006"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Visual acuity and color vision",
              "cadence": "Baseline and monthly while on ethambutol",
              "status": "not_indicated",
              "detail": "Ethambutol stopped a week ago, after normal checks at baseline and two weeks",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Drug susceptibility testing of the first isolate",
              "cadence": "Once, on the first positive culture",
              "status": "completed_today",
              "detail": "Susceptible to isoniazid, rifampin, pyrazinamide, and ethambutol",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Sputum AFB smear and culture",
              "cadence": "Monthly until two consecutive cultures are negative",
              "status": "completed_today",
              "detail": "Three smears in the third week negative; cultures from those samples pending",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Doses observed and missed (video-observed therapy)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "All doses observed",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Peripheral neuropathy check, with pyridoxine",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No neuropathy",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Home isolation and the criteria for release",
              "cadence": "Until three negative smears, clinical improvement, and two weeks of treatment",
              "status": "completed_today",
              "detail": "Release criteria met two weeks ago; back at work, with the health department's agreement",
              "guideline_ids": [
                "GL-CDC-CONTACT-2005",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "referral",
              "measure": "Contact investigation (household, coworkers, patients)",
              "cadence": "Led by the health department, from diagnosis",
              "status": "referred",
              "detail": "In progress with the health department",
              "guideline_ids": [
                "GL-CDC-CONTACT-2005",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "survey",
              "measure": "Alcohol use (AUDIT-C for the past month)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "AUDIT-C 2 for the past month; none in three weeks",
              "observation_ids": [
                "OBS-AUDITC-V3"
              ],
              "guideline_ids": [
                "GL-USPSTF-ALC-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Brief counseling about alcohol and liver risk",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Goal of no alcohol reinforced",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "referral",
              "measure": "Counseling with a substance-use counselor",
              "cadence": "Every one to two weeks during treatment",
              "status": "completed_today",
              "detail": "Two sessions so far",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medication for alcohol use disorder",
              "cadence": "Offered for alcohol use disorder",
              "status": "not_indicated",
              "detail": "Not wanted; doing well with counseling",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review and safety plan, with the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No thoughts of suicide",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            }
          ],
          "follow_up": "Two-month review with sputum culture and liver tests",
          "guideline_ids": [
            "GL-ATS-TB-2016",
            "GL-ATS-HEPATOTOX-2006",
            "GL-CDC-CONTACT-2005",
            "GL-SUD-2021",
            "GL-SUICIDE-2024"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "End of the intensive phase: two-month sputum and the start of the continuation phase",
        "status": "finished",
        "date": "2026-04-14",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "End of the intensive phase: two-month sputum and the start of the continuation phase",
          "hpi": {
            "narrative": "Mr. Holliday returns after nine weeks of treatment. He completed the 56 doses of the intensive phase six days ago, and pyrazinamide was stopped; he now takes isoniazid, rifampin, and pyridoxine daily by video. The cultures from the third week show no growth so far, with the final reading due next week. His cough has gone, and he has gained weight. He has had no nausea, yellowing, dark urine, or numbness. He has had no alcohol for seven weeks and sees his counselor every two weeks. He is working full days.",
            "elements": [
              {
                "label": "Treatment",
                "value": "Intensive phase complete; continuation phase started six days ago"
              },
              {
                "label": "Symptoms",
                "value": "No cough, fever, or night sweats"
              },
              {
                "label": "Weight",
                "value": "62.5 kg, up 4.5 kg since diagnosis"
              },
              {
                "label": "Alcohol",
                "value": "None for seven weeks; AUDIT-C 1"
              }
            ]
          },
          "ros": [
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough, sputum, or blood"
            },
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever or night sweats; appetite good"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No nausea or abdominal pain"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 62.5 kg"
            },
            {
              "system": "Eyes",
              "finding": "No icterus"
            },
            {
              "system": "Respiratory",
              "finding": "Clear apart from a few fine crackles at the right apex"
            },
            {
              "system": "Abdomen",
              "finding": "Liver not enlarged or tender"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Drug-susceptible pulmonary tuberculosis, continuation phase",
              "assessment": "Intensive phase complete with full adherence and a good clinical response. Liver tests normal (ALT 38, AST 35, bilirubin 0.7). Because the disease was cavitary, the two-month culture taken today decides the length of the continuation phase: four months if negative, seven if positive. Dr. Navarro reviewed the plan by message today and agreed",
              "plan": [
                "Continue isoniazid 300 mg, rifampin 600 mg, and pyridoxine daily by video",
                "Sputum smear and culture today (induced, because he no longer coughs up sputum)",
                "Monthly liver tests and symptom review continue"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder, mild",
              "assessment": "No alcohol for seven weeks. Safety reviewed: no thoughts of suicide",
              "plan": [
                "Continue counseling every two weeks",
                "Plan ahead for social events where he used to drink"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Symptom review: cough, sputum, hemoptysis, fever, night sweats",
              "cadence": "At least monthly during treatment",
              "status": "completed_today",
              "detail": "No symptoms",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight",
              "cadence": "At least monthly during treatment",
              "status": "completed_today",
              "detail": "62.5 kg",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Hepatitis symptom review (nausea, vomiting, abdominal pain, jaundice, dark urine)",
              "cadence": "Every visit and every observed dose",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-ATS-TB-2016",
                "GL-ATS-HEPATOTOX-2006"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (ALT, AST, bilirubin)",
              "cadence": "Baseline, at two weeks, then monthly because of alcohol use",
              "status": "completed_today",
              "detail": "ALT 38, AST 35 U/L, bilirubin 0.7 mg/dL, all normal",
              "observation_ids": [
                "OBS-ALT-V4",
                "OBS-AST-V4",
                "OBS-TBIL-V4"
              ],
              "guideline_ids": [
                "GL-ATS-TB-2016",
                "GL-ATS-HEPATOTOX-2006"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Two-month sputum culture",
              "cadence": "At the end of the intensive phase; decides the continuation length in cavitary disease",
              "status": "completed_today",
              "detail": "Induced sputum smear negative today; culture sent, final reading in six weeks",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Sputum AFB smear and culture",
              "cadence": "Monthly until two consecutive cultures are negative",
              "status": "completed_today",
              "detail": "Third-week cultures show no growth so far; final next week",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Chest X-ray",
              "cadence": "At diagnosis; at two months only if the first cultures were negative; at the end of treatment as a new baseline",
              "status": "not_indicated",
              "detail": "Not needed at two months, because the first cultures were positive",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Doses observed and missed (video-observed therapy)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "All 56 intensive-phase doses observed",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Peripheral neuropathy check, with pyridoxine",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No neuropathy",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "referral",
              "measure": "Contact investigation (household, coworkers, patients)",
              "cadence": "Led by the health department, from diagnosis",
              "status": "referred",
              "detail": "Health department continuing; no results are part of his record",
              "guideline_ids": [
                "GL-CDC-CONTACT-2005",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "survey",
              "measure": "Alcohol use (AUDIT-C for the past month)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "AUDIT-C 1 for the past month",
              "observation_ids": [
                "OBS-AUDITC-V4"
              ],
              "guideline_ids": [
                "GL-USPSTF-ALC-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Brief counseling about alcohol and liver risk",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Social events planned for",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "referral",
              "measure": "Counseling with a substance-use counselor",
              "cadence": "Every one to two weeks during treatment",
              "status": "completed_today",
              "detail": "Every two weeks",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review and safety plan, with the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No thoughts of suicide",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "referral",
              "measure": "Infectious diseases review",
              "cadence": "At two months and at the end of treatment",
              "status": "completed_today",
              "detail": "Dr. Navarro reviewed the plan by message today",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            }
          ],
          "follow_up": "End-of-treatment visit after the last dose. Monthly liver tests and symptom review in between. Call the same day for hepatitis symptoms or a returning cough",
          "guideline_ids": [
            "GL-ATS-TB-2016",
            "GL-ATS-HEPATOTOX-2006",
            "GL-CDC-CONTACT-2005",
            "GL-SUD-2021",
            "GL-SUICIDE-2024"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "End-of-treatment review after six months",
        "status": "finished",
        "date": "2026-08-18",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "End-of-treatment review after six months",
          "hpi": {
            "narrative": "Mr. Holliday returns five days after his last dose. He completed all 182 doses by video-observed therapy: 56 in the intensive phase and 126 in the continuation phase, with the one dose held during the stomach illness in the spring added at the end. The cultures from the third week and from the two-month visit both grew nothing, so the continuation phase stayed at four months. He has had no cough, fever, night sweats, or weight loss for months, and he has gained 7.5 kg. The repeat liver tests planned two weeks after the sick visit, and the monthly tests in the fourth and fifth months, were not drawn; he reported no hepatitis symptoms on any video call. Since the party in the spring he has had a drink or two at most once a week and no heavy drinking. He sees his counselor once a month.",
            "elements": [
              {
                "label": "Treatment",
                "value": "All 182 doses completed by video-observed therapy"
              },
              {
                "label": "Cultures",
                "value": "Third-week and two-month cultures negative"
              },
              {
                "label": "Weight",
                "value": "65.5 kg, up 7.5 kg since diagnosis"
              },
              {
                "label": "Alcohol",
                "value": "AUDIT-C 3; no heavy drinking since the spring"
              }
            ]
          },
          "ros": [
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough, sputum, hemoptysis, or breathlessness"
            },
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever, night sweats, or weight loss"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No nausea, abdominal pain, or jaundice"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No numbness or tingling"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-9 3; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 65.5 kg, BMI 20.7"
            },
            {
              "system": "Eyes",
              "finding": "No icterus"
            },
            {
              "system": "Respiratory",
              "finding": "Clear, with no crackles"
            },
            {
              "system": "Abdomen",
              "finding": "Liver not enlarged"
            },
            {
              "system": "Neurological",
              "finding": "Normal sensation in the feet"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Drug-susceptible pulmonary tuberculosis, treatment completed",
              "assessment": "Treatment completed, with culture conversion and a full clinical response. The chest X-ray today shows the cavity closed, with residual scarring in the right upper lobe. End-of-treatment ALT 30, AST 28, bilirubin 0.6, and hemoglobin 14.4, all normal. Dr. Navarro reviewed the results by message today and advises no routine follow-up after treatment",
              "plan": [
                "No further tuberculosis medicine",
                "Return the same day for cough lasting more than two weeks, fever, night sweats, or weight loss, which could mean relapse",
                "Keep today's chest X-ray as the baseline for any future comparison",
                "Health department notified that treatment is complete"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder, mild, improving",
              "assessment": "Low-risk drinking since the spring. AUDIT-C 3, PHQ-9 3. Safety reviewed: no thoughts of suicide",
              "plan": [
                "Continue monthly counseling",
                "Keep to no more than two drinks on any day"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Symptom review: cough, sputum, hemoptysis, fever, night sweats",
              "cadence": "At least monthly during treatment",
              "status": "completed_today",
              "detail": "No symptoms",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight",
              "cadence": "At least monthly during treatment",
              "status": "completed_today",
              "detail": "65.5 kg",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Hepatitis symptom review (nausea, vomiting, abdominal pain, jaundice, dark urine)",
              "cadence": "Every visit and every observed dose",
              "status": "completed_today",
              "detail": "None reported at any observed dose",
              "guideline_ids": [
                "GL-ATS-TB-2016",
                "GL-ATS-HEPATOTOX-2006"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (ALT, AST, bilirubin)",
              "cadence": "Baseline, at two weeks, then monthly because of alcohol use",
              "status": "completed_today",
              "detail": "ALT 30, AST 28 U/L, bilirubin 0.6 mg/dL, all normal at the end of treatment",
              "observation_ids": [
                "OBS-ALT-V5",
                "OBS-AST-V5",
                "OBS-TBIL-V5"
              ],
              "guideline_ids": [
                "GL-ATS-TB-2016",
                "GL-ATS-HEPATOTOX-2006"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests after the sick visit and in months four and five",
              "cadence": "Two weeks after the sick visit, then monthly",
              "status": "deferred",
              "detail": "Not drawn: no visit was scheduled between the sick visit and the end of treatment, and no standing order was placed. He reported no hepatitis symptoms on daily video calls, and the end-of-treatment tests are normal, so no harm is evident. Corrective action: standing monthly liver-test orders at the start of treatment for every patient with a risk factor",
              "guideline_ids": [
                "GL-ATS-TB-2016",
                "GL-ATS-HEPATOTOX-2006"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin",
              "cadence": "At the end of treatment when low at baseline",
              "status": "completed_today",
              "detail": "14.4 g/dL, up from 12.6 at diagnosis",
              "observation_ids": [
                "OBS-HGB-V5"
              ],
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Sputum AFB smear and culture",
              "cadence": "Monthly until two consecutive cultures are negative",
              "status": "completed_today",
              "detail": "Two consecutive negative cultures (third week and two months); no further sputum needed",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Two-month sputum culture",
              "cadence": "At the end of the intensive phase; decides the continuation length in cavitary disease",
              "status": "completed_today",
              "detail": "No growth; continuation phase kept at four months",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Chest X-ray",
              "cadence": "At diagnosis; at two months only if the first cultures were negative; at the end of treatment as a new baseline",
              "status": "completed_today",
              "detail": "Cavity closed; residual right upper lobe scarring",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Doses observed and missed (video-observed therapy)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "All 182 doses observed",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Peripheral neuropathy check, with pyridoxine",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No neuropathy; pyridoxine stopped with isoniazid",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "referral",
              "measure": "Notification of treatment completion to the health department",
              "cadence": "At the end of treatment",
              "status": "completed_today",
              "detail": "Sent today",
              "guideline_ids": [
                "GL-CDC-CONTACT-2005",
                "GL-ATS-TB-2016"
              ]
            },
            {
              "domain": "survey",
              "measure": "Alcohol use (AUDIT-C for the past month)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "AUDIT-C 3 for the past month",
              "observation_ids": [
                "OBS-AUDITC-V5"
              ],
              "guideline_ids": [
                "GL-USPSTF-ALC-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Brief counseling about alcohol and liver risk",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Low-risk limits agreed now that treatment is over",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "referral",
              "measure": "Counseling with a substance-use counselor",
              "cadence": "Every one to two weeks during treatment",
              "status": "completed_today",
              "detail": "Monthly",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9)",
              "cadence": "At diagnosis and at the end of treatment",
              "status": "completed_today",
              "detail": "PHQ-9 3, item 9 scored 0",
              "observation_ids": [
                "OBS-PHQ9-V5"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review and safety plan, with the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No thoughts of suicide",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "referral",
              "measure": "Infectious diseases review",
              "cadence": "At two months and at the end of treatment",
              "status": "completed_today",
              "detail": "Dr. Navarro reviewed the end-of-treatment results by message; no routine follow-up",
              "guideline_ids": [
                "GL-ATS-TB-2016"
              ]
            }
          ],
          "follow_up": "Adult preventive visit in about a month. Same-day visit for symptoms of relapse",
          "guideline_ids": [
            "GL-ATS-TB-2016",
            "GL-ATS-HEPATOTOX-2006",
            "GL-CDC-CONTACT-2005",
            "GL-SUD-2021",
            "GL-SUICIDE-2024",
            "GL-USPSTF-DEP-2023"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Same-day sick visit for nausea and vomiting during tuberculosis treatment",
        "status": "finished",
        "date": "2026-05-19",
        "visit_type": "sick",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "185345009",
          "display": "Encounter for symptom",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Nausea, vomiting, and loose stools for two days during tuberculosis treatment",
          "billing_note": "Problem-oriented office visit, established patient",
          "hpi": {
            "narrative": "Mr. Holliday is a 21-year-old dentist with drug-susceptible cavitary pulmonary tuberculosis in the sixth week of the continuation phase of isoniazid and rifampin, given by video-observed therapy, and with a mild alcohol use disorder. Two days ago he developed nausea and loose stools, and he vomited twice yesterday; two coworkers at the dental office had a stomach illness last week. When he reported the nausea on his video call this morning, the health department nurse told him to hold today's doses, as his treatment plan instructs, and to be seen today with liver tests. He has no yellowing of the eyes or skin, no dark urine or pale stools, no pain under the right ribs, and no itching or rash. His cough has gone and he has had no fevers or night sweats. He has not missed any other dose. He told us that nine days ago, at a friend's birthday party, he drank about six whiskeys over an evening, the first time he has drunk heavily since starting treatment; he has not drunk since. He feels he let himself down but has no thoughts of suicide.",
            "elements": [
              {
                "label": "Onset",
                "value": "Two days ago"
              },
              {
                "label": "Location",
                "value": "Upper abdomen and bowel"
              },
              {
                "label": "Duration",
                "value": "Two days"
              },
              {
                "label": "Character",
                "value": "Nausea, two vomits, and loose stools"
              },
              {
                "label": "Severity",
                "value": "Mild to moderate; drinking fluids"
              },
              {
                "label": "Timing",
                "value": "Sixth week of the continuation phase"
              },
              {
                "label": "Context",
                "value": "Coworkers with a stomach illness; one evening of heavy drinking nine days ago"
              },
              {
                "label": "Modifying factors",
                "value": "Today's doses held on the nurse's advice"
              },
              {
                "label": "Associated signs and symptoms",
                "value": "No jaundice, dark urine, right upper abdominal pain, rash, or fever"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired with the illness; no fever or night sweats"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No yellowing of the eyes; vision normal"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough, sputum, or breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "positive",
              "finding": "Nausea, two vomits yesterday, and loose stools; no right upper abdominal pain, blood, or pale stools"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "Urine orange from rifampin as expected, not dark brown"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No jaundice, rash, or itching"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No numbness or tingling of the hands or feet"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Disappointed about the party; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Tired but well-appearing; weight 61.8 kg, down 0.7 kg from the last visit"
            },
            {
              "system": "Eyes",
              "finding": "No scleral icterus"
            },
            {
              "system": "Mouth",
              "finding": "Mucous membranes slightly dry"
            },
            {
              "system": "Respiratory",
              "finding": "Clear; a few fine crackles at the right apex that clear with coughing"
            },
            {
              "system": "Abdomen",
              "finding": "Soft, mildly tender around the umbilicus; liver not enlarged or tender; no guarding"
            },
            {
              "system": "Skin",
              "finding": "No jaundice or rash"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Acute viral gastroenteritis",
              "assessment": "A short illness shared with coworkers, with loose stools, no fever, and a benign abdomen. ALT 64 and AST 58 U/L are only just above normal, with normal bilirubin 0.9 and alkaline phosphatase 98. Drug-induced liver injury is defined as ALT at least three times the upper limit with symptoms, or five times without; ALT here is about 1.1 times the upper limit, so this is not drug-induced liver injury. The small rise fits the recent heavy drinking and the viral illness",
              "plan": [
                "Oral fluids and a bland diet; no antiemetic needed now",
                "Hand washing; stay off work until two days after the symptoms stop"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Pulmonary tuberculosis, continuation phase",
              "assessment": "Clinically well on treatment, with no cough or fever. One day's doses held today",
              "plan": [
                "Resume isoniazid and rifampin tomorrow under video-observed therapy once he can keep food down; the missed dose is added at the end, so the last dose moves one day later",
                "Repeat liver tests in two weeks",
                "Stop the doses and call the same day for yellow eyes or skin, dark urine, right upper abdominal pain, or vomiting that returns"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder, mild, with one lapse",
              "assessment": "One evening of heavy drinking after more than two months with little or none. AUDIT-C 4. A lapse he has reported openly. Safety reviewed: no thoughts of suicide; the 988 Suicide & Crisis Lifeline is in his phone",
              "plan": [
                "Brief counseling today about the extra liver risk from alcohol on isoniazid; he recommits to no alcohol until treatment ends",
                "Plan for parties: arrive with a non-alcoholic drink and leave early, and tell one friend his goal",
                "Next session with his substance-use counselor this week"
              ]
            }
          ],
          "follow_up": "Health department nurse to confirm the restart on tomorrow's video call. Liver tests in two weeks. End-of-treatment visit in the summer",
          "guideline_ids": [
            "GL-IDSA-GE-2017",
            "GL-ATS-HEPATOTOX-2006",
            "GL-ATS-TB-2016",
            "GL-SUD-2021"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic unscheduled sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-03T16:00:00-05:00"
        }
      },
      {
        "id": "ENC-007",
        "display": "Adult preventive visit",
        "status": "finished",
        "date": "2026-09-22",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Adult preventive visit; no new complaints",
          "billing_note": "CPT 99395 (periodic preventive medicine, established patient, age 18 to 39)",
          "hpi": {
            "narrative": "Mr. Holliday returns for his adult preventive visit five weeks after his end-of-treatment review. He finished all 182 doses of tuberculosis treatment and has had no cough, fever, night sweats, or weight loss since. He is working full days at the dental office. He has kept to one or two drinks once a week, with no evening of heavy drinking since the spring, and he still sees his substance-use counselor once a month. He completed the health risk assessment before the visit.",
            "elements": [
              {
                "label": "Visit",
                "value": "Adult preventive visit, age 22"
              },
              {
                "label": "Active conditions",
                "value": "Pulmonary tuberculosis, treatment completed; alcohol use disorder, mild, improving"
              },
              {
                "label": "Medicines",
                "value": "None since tuberculosis treatment ended"
              },
              {
                "label": "Functional status",
                "value": "Independent; working full days"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Good, much better than at the start of the year"
            },
            {
              "domain": "Psychosocial",
              "finding": "Shares an apartment with a roommate; friends nearby; work going well"
            },
            {
              "domain": "Behavioral",
              "finding": "One or two drinks once a week (AUDIT-C 3); no tobacco or other drugs; plays cards on weekends, home by midnight"
            },
            {
              "domain": "Nutrition",
              "finding": "Three meals a day; weight up 8 kg since diagnosis"
            },
            {
              "domain": "Physical activity",
              "finding": "Walks to work; no other exercise"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent in all"
            },
            {
              "domain": "Occupational",
              "finding": "Dentist; wears a surgical mask and eye protection with every patient and an N95 respirator for aerosol-generating procedures in patients with suspected tuberculosis"
            },
            {
              "domain": "Sleep",
              "finding": "About seven hours a night"
            },
            {
              "domain": "Safety",
              "finding": "Wears a seat belt; no firearms at home; smoke detector working"
            },
            {
              "domain": "Hearing and vision",
              "finding": "No concerns; vision normal at the end of ethambutol"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Weight up; no fever or night sweats"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No blurred vision or color change"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No sore throat or hoarseness"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or palpitations"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough, sputum, hemoptysis, or breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No nausea or abdominal pain"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary symptoms"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No joint pain"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No numbness or tingling"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-2 score 0"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well-appearing; BMI 20.8"
            },
            {
              "system": "Eyes",
              "finding": "Conjunctivae normal; no icterus"
            },
            {
              "system": "Ears, nose, and throat",
              "finding": "Normal"
            },
            {
              "system": "Neck",
              "finding": "No lymph nodes"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur"
            },
            {
              "system": "Respiratory",
              "finding": "Clear; no crackles"
            },
            {
              "system": "Abdomen",
              "finding": "Soft; liver not enlarged"
            },
            {
              "system": "Skin",
              "finding": "No rash or suspicious lesions"
            },
            {
              "system": "Neurological",
              "finding": "Normal sensation in the feet"
            },
            {
              "system": "Psychiatric",
              "finding": "Relaxed and engaged"
            }
          ],
          "assessment_plan": [
            {
              "display": "Adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and a written prevention plan given. PHQ-2 0. AUDIT-C 3, below the risk threshold for men",
              "plan": [
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Pulmonary tuberculosis, treatment completed",
              "assessment": "No symptoms of relapse",
              "plan": [
                "Yearly symptom screen at work instead of a skin or blood test, which would stay positive",
                "Same-day visit for cough lasting more than two weeks, fever, night sweats, or weight loss"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder, mild, improving",
              "assessment": "Drinking within low-risk limits since the spring. Safety reviewed: no thoughts of suicide",
              "plan": [
                "Continue monthly counseling for three more months, then as needed"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Influenza vaccine, 2026-2027",
              "status": "completed_today",
              "detail": "Given today; recommended for health-care personnel",
              "guideline_ids": [
                "GL-CDC-ADULT-2026",
                "GL-ACIP-HCP-2011"
              ]
            },
            {
              "service": "Hepatitis B vaccine",
              "status": "completed_today",
              "detail": "Not immune at diagnosis (surface antigen and surface antibody negative). First of two HepB-CpG doses today; second in one month; surface antibody one to two months after the second dose, as for all health-care personnel",
              "guideline_ids": [
                "GL-CDC-ADULT-2026",
                "GL-ACIP-HCP-2011"
              ]
            },
            {
              "service": "COVID-19 vaccine, 2026-2027",
              "status": "due",
              "detail": "Recommended; he will get it at his pharmacy",
              "guideline_ids": [
                "GL-CDC-ADULT-2026"
              ]
            },
            {
              "service": "Measles, mumps, rubella and varicella immunity",
              "status": "up_to_date",
              "detail": "Two documented doses of each in his childhood record, as required for health-care personnel",
              "guideline_ids": [
                "GL-ACIP-HCP-2011"
              ]
            },
            {
              "service": "Tetanus, diphtheria, and pertussis booster",
              "status": "up_to_date",
              "detail": "Tdap about four years ago",
              "guideline_ids": [
                "GL-CDC-ADULT-2026"
              ]
            },
            {
              "service": "HPV vaccine",
              "status": "up_to_date",
              "detail": "Series completed in adolescence by his report",
              "guideline_ids": [
                "GL-CDC-ADULT-2026"
              ]
            },
            {
              "service": "HIV screening",
              "status": "up_to_date",
              "detail": "Negative at the tuberculosis diagnosis",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Hepatitis C screening",
              "status": "up_to_date",
              "detail": "Antibody negative at the tuberculosis diagnosis",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Tuberculosis screening at work",
              "status": "not_indicated",
              "detail": "A skin or blood test stays positive after tuberculosis; a yearly symptom screen replaces it"
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-2 score 0",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "service": "Unhealthy alcohol use screening",
              "status": "completed_today",
              "detail": "AUDIT-C 3, below the risk threshold; counseling continues",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018"
              ]
            },
            {
              "service": "Tobacco use",
              "status": "completed_today",
              "detail": "Never used"
            },
            {
              "service": "Blood pressure screening",
              "status": "completed_today",
              "detail": "118/72 mmHg",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Diabetes screening",
              "status": "not_indicated",
              "detail": "BMI 20.8 with no risk factors; HbA1c 5.2 percent at diagnosis",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Sexual health and STI screening",
              "status": "completed_today",
              "detail": "Discussed privately; no screening indicated by his history; condoms discussed",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            }
          ],
          "advance_care_planning": "Brief voluntary discussion, offered because of this year's serious illness. He wants to think about whom to name as his health care agent and was given the state's health care directive form to complete at home. No treatment preferences are recorded.",
          "follow_up": "Second hepatitis B dose in one month at a nurse visit, and surface antibody one to two months after it. Next preventive visit in one year",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-CDC-ADULT-2026",
            "GL-ACIP-HCP-2011"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-03T16:00:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-02-10",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 58.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 18.3,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 112,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 70,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 104,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 20,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.8,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 95,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic seated vital signs with low-grade fever and tachycardia from active tuberculosis.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-02-24",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 59.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 18.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 114,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 72,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 92,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 18,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.3,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 96,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-03-17",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 61.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 19.3,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 116,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 72,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 84,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.8,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-04-14",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 62.5,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 19.7,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 116,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 78,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-08-18",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 65.5,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 20.7,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 118,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-05-19",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 61.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 19.5,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 108,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 68,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 98,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.4,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs during a viral gastroenteritis.",
          "author": "The Human Record generator",
          "created": "2026-11-03T16:00:00-05:00"
        }
      },
      {
        "id": "VSET-007",
        "date": "2026-09-22",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 178,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 66.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 20.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 118,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 72,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 68,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-03T16:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Newly qualified dentist in his first year of practice, an associate in a group dental office; works close to patients' faces",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic modern occupation anchored to his documented dental career and early qualification.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Shares an apartment with one roommate; no children in the household; no one in the home with a weakened immune system",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic household, recorded for the contact investigation and home isolation; it names no real person.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Alcohol: whiskey four or more evenings a week, often six or more drinks, mostly at card games late at night; AUDIT 15. Meets three criteria for alcohol use disorder in the past year",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic modern drinking history anchored to the documented heavy drinking and late nights.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Plays poker for money several nights a week; up late most nights",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic modern history anchored to the documented card playing and late nights.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "No tobacco or other drug use; no travel outside the country; no incarceration or homelessness",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic risk-factor history for tuberculosis and HIV testing.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent; working full days until the cough and night sweats wore him down over the last month",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic functional status.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, sharp, and dryly humorous; organized thought; no signs of intoxication or withdrawal",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "MSE-002",
        "display": "Mood worried about his work and his health; PHQ-9 6; no thoughts of suicide or self-harm",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "safety_assessment": {
      "id": "SAFE-001",
      "date": "2026-02-10",
      "current_ideation": "absent",
      "intent": "absent",
      "plan": "absent",
      "access_reviewed": true,
      "protective_factors": [
        "A profession he worked hard to qualify for",
        "A roommate and friends nearby",
        "Willing to cut down his drinking",
        "Engagement in care"
      ],
      "disposition": "Routine outpatient care. A new serious diagnosis, isolation, and heavy drinking can raise suicide risk, so safety is reviewed at every visit. He saved the 988 Suicide & Crisis Lifeline in his phone. No firearm in the home",
      "provenance": {
        "evidence_grade": "S",
        "claim_ids": [
          "CLM-0006"
        ],
        "synthetic_reason": "Synthetic present-day structured safety assessment required by the alcohol use disorder code; it records no current risk and makes no claim about his real mental health.",
        "author": "The Human Record generator",
        "created": "2026-11-02T15:00:00-05:00"
      }
    },
    "consultation": {
      "referral": {
        "question": "New cavitary, smear-positive pulmonary tuberculosis in a 21-year-old dentist who drinks heavily. Please confirm the regimen and doses, advise on liver monitoring given his alcohol use, and advise on isolation, return to dental work, and the length of treatment",
        "urgency": "Urgent, within two weeks, on the same day as his two-week primary care visit",
        "pertinent_history": "Two months of cough, blood-streaked sputum, night sweats, and weight loss to 58.0 kg (BMI 18.3); temperature 37.8 °C, oxygen saturation 95 percent. Chest X-ray: right upper lobe consolidation with a 3 cm cavity. First sputum smear for acid-fast bacilli 2+ today; two early-morning samples to follow, and a nucleic acid amplification test, culture, and susceptibility testing ordered. HIV, hepatitis B, and hepatitis C tests sent. Baseline ALT 34, AST 38, bilirubin 0.6, GGT 78 (high), albumin 3.4 (low), hemoglobin 12.6 (low), platelets 412 (high), HbA1c 5.2, creatinine 0.86. Visual acuity 85 letters in each eye with normal color vision. Alcohol: AUDIT 15, whiskey four or more evenings a week, often six or more drinks, mostly at late-night card games; mild alcohol use disorder; brief intervention given; safety assessment with no current risk. No other medicines; no known allergies. Plan: isoniazid 300 mg, rifampin 600 mg, pyrazinamide 1500 mg, ethambutol 1200 mg, and pyridoxine 50 mg daily by video-observed therapy with the health department, starting as soon as the amplification test confirms tuberculosis. Reported to the health department today; isolating at home",
        "questions": [
          "Do you agree with the regimen and the weight-based doses?",
          "How should his liver be monitored, given his drinking, and when should the drugs be stopped?",
          "When can he leave home isolation and return to treating patients?",
          "How long should treatment last, given the cavity, and is the four-month rifapentine and moxifloxacin regimen an option?",
          "When can ethambutol be stopped?",
          "Is any other testing or follow-up needed from infectious diseases?"
        ]
      },
      "consultant_note": {
        "history": "Mr. Holliday, a 21-year-old dentist, is seen at the request of Dr. Beaumont two weeks after a diagnosis of cavitary pulmonary tuberculosis. He has taken all thirteen doses of isoniazid, rifampin, pyrazinamide, and ethambutol with pyridoxine by video-observed therapy. His cough and night sweats are improving and the hemoptysis has stopped. He has mild nausea after the morning doses and orange urine and tears, and no jaundice, abdominal pain, rash, numbness, or vision change. He has cut his drinking down sharply. He has no travel outside the country, no known contact with drug-resistant tuberculosis, and no immune-suppressing condition or medicine",
        "data_reviewed": "Dr. Beaumont's diagnostic note; the chest X-ray; the three baseline smears and the nucleic acid amplification result; today's report that the baseline cultures are growing Mycobacterium tuberculosis complex, with susceptibility pending; the HIV, hepatitis B, and hepatitis C results, all negative, with no hepatitis B immunity; and today's liver tests and vision check",
        "exam": [
          {
            "system": "General",
            "finding": "Thin; temperature 37.3 °C, heart rate 92; seen in a negative-pressure room"
          },
          {
            "system": "Eyes",
            "finding": "No icterus; visual acuity and color vision normal"
          },
          {
            "system": "Respiratory",
            "finding": "Coarse crackles and bronchial breathing over the right upper zone"
          },
          {
            "system": "Abdomen",
            "finding": "Soft, non-tender; liver not enlarged"
          },
          {
            "system": "Neurological",
            "finding": "Normal sensation in the feet"
          },
          {
            "system": "Skin",
            "finding": "No rash"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-001",
            "display": "Cavitary pulmonary tuberculosis, probably drug-susceptible",
            "assessment": "Smear-positive, culture-positive cavitary disease with an early clinical response and full adherence. No rifampin resistance on the molecular test; isoniazid susceptibility is pending. The regimen and the weight-band doses are correct: isoniazid about 5 mg/kg, rifampin about 10 mg/kg, pyrazinamide 1500 mg and ethambutol 1200 mg for 56 to 75 kg. HIV negative"
          },
          {
            "display": "Liver risk",
            "assessment": "Heavy drinking, low albumin, and the three hepatotoxic drugs together raise his risk of drug-induced liver injury. Today's ALT 41, AST 39, and bilirubin 0.7 are normal. Injury is defined as ALT at least three times the upper limit with symptoms, or at least five times without symptoms, or a bilirubin rise; small rises below this are common and do not need the drugs stopped"
          },
          {
            "display": "Infectiousness and return to work",
            "assessment": "He remains infectious until he has three negative sputum smears, a clinical response, and at least two weeks of effective treatment. Because he works close to patients' faces, return should wait for all three"
          },
          {
            "display": "Length of treatment",
            "assessment": "Six months in total if the two-month culture is negative. A cavity on the first X-ray together with a positive two-month culture would extend the continuation phase to seven months. The four-month rifapentine and moxifloxacin regimen is an alternative only at the start of treatment; switching now offers no benefit"
          },
          {
            "problem_id": "PRB-002",
            "display": "Alcohol use disorder, mild",
            "assessment": "Stopping alcohol is the most useful thing he can do for his liver during treatment. If medication is wanted, acamprosate is preferred, because it is not processed by the liver; naltrexone and disulfiram are best avoided while he is on hepatotoxic drugs"
          }
        ],
        "recommendations": [
          "Continue isoniazid 300 mg, rifampin 600 mg, pyrazinamide 1500 mg, ethambutol 1200 mg, and pyridoxine 50 mg daily by video-observed therapy, seven days a week, for the 56-dose intensive phase; bedtime dosing with a snack for the nausea",
          "Stop ethambutol once the isolate is shown to be susceptible to isoniazid and rifampin",
          "Visual acuity and color vision monthly while on ethambutol",
          "Liver tests monthly throughout treatment because of his drinking, and at once for any nausea, vomiting, abdominal pain, jaundice, or dark urine; the health department nurse should hold doses for those symptoms until results are back",
          "Stop all hepatotoxic drugs if ALT reaches three times the upper limit with symptoms, or five times without, and call me",
          "Three sputum smears on consecutive mornings in the third week; release from home isolation and return to dental work when all three are negative, with continued clinical improvement",
          "Sputum smear and culture monthly until two consecutive cultures are negative, including a culture at the end of the intensive phase",
          "Continuation phase of isoniazid and rifampin for four months if the two-month culture is negative, or seven months if it is positive",
          "No alcohol during treatment; counseling with a substance-use counselor; acamprosate if medication is wanted",
          "Hepatitis B vaccination, which can wait until treatment ends",
          "I will review the results by message at two months and at the end of treatment; no infectious diseases visit is needed unless the cultures stay positive, a drug must be stopped, or resistance is found"
        ],
        "communication": "Discussed with Dr. Beaumont, who sees him the same day, and with the health department tuberculosis nurse who supervises his video-observed therapy. The plan, the warning symptoms of liver injury, and the criteria for returning to work were explained to Mr. Holliday, who agreed with them",
        "follow_up": "Results review by message at two months and at the end of treatment; sooner for liver injury, persistent positive cultures, or drug resistance"
      },
      "guideline_ids": [
        "GL-ATS-TB-2016",
        "GL-ATS-TB-2025",
        "GL-ATS-HEPATOTOX-2006",
        "GL-CDC-CONTACT-2005",
        "GL-SUD-2021"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "He wants to get back to his dental practice as soon as it is safe for his patients",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "He is frightened by the diagnosis and wants to know that it can be cured",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Complete 182 doses of treatment under video-observed therapy within six months",
        "status": "completed",
        "target_date": "2026-08-18",
        "outcome": "All 182 doses completed: 56 in the intensive phase and 126 in the continuation phase, with one dose held during a stomach illness and made up at the end",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic treatment-completion goal.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "Sputum culture negative at two months",
        "status": "completed",
        "target_date": "2026-08-18",
        "outcome": "Two-month culture showed no growth, so the continuation phase stayed at four months",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic culture-conversion goal.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "No alcohol during treatment, to protect his liver",
        "status": "active",
        "target_date": "2026-08-18",
        "outcome": "Not fully met: no drinking for most of the six months, with one evening of heavy drinking at a party about three months into treatment; AUDIT-C 3 at the end",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alcohol goal.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Return to work once he is no longer infectious",
        "status": "completed",
        "target_date": "2026-03-17",
        "outcome": "Released from home isolation after three negative sputum smears and back at work four weeks into treatment",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic occupational goal.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "Weight back to at least 64 kg by the end of treatment",
        "status": "completed",
        "target_date": "2026-08-18",
        "outcome": "65.5 kg at the end of treatment, from 58.0 kg at diagnosis",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic nutrition goal.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Infectious diseases consultation to confirm the regimen and plan monitoring for cavitary pulmonary tuberculosis in a man who drinks heavily",
        "status": "completed",
        "guideline_ids": [
          "GL-ATS-TB-2016",
          "GL-ATS-TB-2025"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic specialist consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Standard treatment: isoniazid, rifampin, pyrazinamide, and ethambutol for eight weeks, then isoniazid and rifampin for eighteen weeks, by video-observed therapy with the health department, with pyridoxine",
        "status": "completed",
        "guideline_ids": [
          "GL-ATS-TB-2016"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic treatment plan.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Monitoring: monthly symptom and weight check, sputum smear and culture monthly until two consecutive cultures are negative, liver tests at two weeks and monthly because of alcohol, and vision checks while on ethambutol",
        "status": "completed",
        "guideline_ids": [
          "GL-ATS-TB-2016",
          "GL-ATS-HEPATOTOX-2006"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic monitoring plan.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Public health: same-day report to the local health department, home isolation until noninfectious, and a contact investigation of his household, coworkers, and patients led by the health department",
        "status": "completed",
        "guideline_ids": [
          "GL-CDC-CONTACT-2005",
          "GL-ATS-TB-2016"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic public-health plan.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "INT-005",
        "display": "Alcohol care: brief intervention at diagnosis, a goal of no alcohol during treatment, counseling with a substance-use counselor, medication offered, AUDIT-C at each visit, and a safety review with the 988 Suicide & Crisis Lifeline at every visit",
        "status": "completed",
        "guideline_ids": [
          "GL-USPSTF-ALC-2018",
          "GL-SUD-2021",
          "GL-SUICIDE-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic alcohol-care plan.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-ATS-TB-2016",
        "title": "Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis",
        "publisher": "American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America (Clinical Infectious Diseases)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/27621353/",
        "version_or_year": "2016"
      },
      {
        "guideline_id": "GL-ATS-TB-2025",
        "title": "Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline",
        "publisher": "American Thoracic Society, Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America (American Journal of Respiratory and Critical Care Medicine)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/40693952/",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-ATS-HEPATOTOX-2006",
        "title": "An official ATS statement: hepatotoxicity of antituberculosis therapy",
        "publisher": "American Thoracic Society (American Journal of Respiratory and Critical Care Medicine)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/17021358/",
        "version_or_year": "2006"
      },
      {
        "guideline_id": "GL-CDC-CONTACT-2005",
        "title": "Guidelines for the investigation of contacts of persons with infectious tuberculosis: recommendations from the National Tuberculosis Controllers Association and CDC",
        "publisher": "Centers for Disease Control and Prevention (MMWR Recommendations and Reports)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/16357823/",
        "version_or_year": "2005"
      },
      {
        "guideline_id": "GL-USPSTF-ALC-2018",
        "title": "Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-SUD-2021",
        "title": "VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders",
        "publisher": "United States Department of Veterans Affairs and Department of Defense",
        "url": "https://www.healthquality.va.gov/guidelines/MH/sud/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-SUICIDE-2024",
        "title": "VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide",
        "publisher": "United States Department of Veterans Affairs and Department of Defense",
        "url": "https://healthquality.va.gov/HEALTHQUALITY/guidelines/mh/srb/index.asp",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-IDSA-GE-2017",
        "title": "2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea",
        "publisher": "Infectious Diseases Society of America (Clinical Infectious Diseases)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/29053792/",
        "version_or_year": "2017"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-CDC-ADULT-2026",
        "title": "Adult Immunization Schedule by Age",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ACIP-HCP-2011",
        "title": "Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP)",
        "publisher": "Centers for Disease Control and Prevention (MMWR Recommendations and Reports)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/22108587/",
        "version_or_year": "2011"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Biographical facts from the New Georgia Encyclopedia, the Encyclopedia of the Great Plains, and HISTORY.com. The birth year conflict (1851 or 1852) is recorded. The heavy drinking is documented but undated; its placement at the time of diagnosis is synthetic."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "Alcohol claims are marked sensitive; the safety assessment records no current risk and gives the 988 Suicide & Crisis Lifeline; no contact is named; death recorded without detail."
    }
  }
}
